HLTH 2022 Roundup: Mirvie, Grail, Biofourmis, Komodo Health, Babson Diagnostics

 
• By Marion Webb

This year’s annual HLTH meeting drew more than 9,000 people to Las Vegas from 13-16 November and hundreds of exhibitors. In this first part of a two-part roundup, Medtech Insight highlights interviews with C-suite executives at Mirvie, Grail, Biofourmis, Komodo Health and Babson Diagnostics.

HLTH 2022
• Source: Medtech Insight

The fifth annual HLTH conference in Las Vegas delighted attendees with a full schedule, sessions focusing on hot topics such as women’s health and health equity, interesting panel discussions on fun-themed stages, and a jam-packed exhibit hall with healthtech companies strutting their stuff. (Also see "HLTH Conference Promises Festival Vibe On One Big Stage; Health Equity, Women’s Health, Digital Health" - Medtech Insight, 11 November, 2022.)

Medtech Insight sat down with top executives of Mirvie, Inc., GRAIL, Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight